Download PDF
Semin Neurol 2002; 22(3): 299-308
DOI: 10.1055/s-2002-36649
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Pregnancy in the Woman with Epilepsy: Maternal and Fetal Outcomes

Page B. Pennell
  • Emory Epilepsy Monitoring Unit, Emory University School of Medicine, Atlanta, Georgia
Further Information

Publication History

Publication Date:
15 January 2003 (online)

    Permissions and Reprints

ABSTRACT

Pregnancy in women with epilepsy is associated with increased obstetric risks and increased adverse neonatal outcomes. Prior to conception, folic acid should be administered and the antiepileptic drug (AED) regimen should be optimized. Effective control of maternal seizures with the least risk to the fetus is the goal, preferably using AED monotherapy. Periodic monitoring of total and free AED levels is recommended. The "fetal anticonvulsant syndrome" has been described with all of the AEDs and includes major malformations, minor anomalies, microcephaly, cognitive impairment, intrauterine growth retardation, and infant mortality. The most common major malformations are cleft lip/palate, heart defects, and neural tube defects. Prenatal screening should be offered. Supplemental vitamin K1 should be given to the mother and newborn to prevent neonatal hemorrhagic disorder. Careful planning and management of any pregnancy in women with epilepsy are essential to increase the likelihood of a healthy outcome for the mother and infant.

KEYWORD

Epilepsy - women - pregnancy - anticonvulsants - teratogenesis

REFERENCES

  • 1 Yerby M S. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy.  Neurology . 2000;  55(5 suppl 1) S21-S58
    PubMedGoogle Scholar
  • 2 Janz D, Schmidt D. Anti-epileptic drugs and failure of oral contraceptives [letter].  Lancet . 1974;  1 1113
    PubMedGoogle Scholar
  • 3 Guberman A. Hormonal contraception and epilepsy.  Neurology . 1999;  53 (suppl 1) S38-S40
    PubMedGoogle Scholar
  • 4 Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement).  Neurology . 1998;  51 944-948
    PubMedGoogle Scholar
  • 5 Morrell M J, Sarto G E, Shafer P O, Borda E A, Herzog A, Callanan M. Health issues for women with epilepsy: a descriptive survey to assess knowledge and awareness among healthcare providers.  J Womens Health Gend Based Med . 2000;  9 959-965
    CrossrefPubMedGoogle Scholar
  • 6 Krauss G, Brandt J, Campbell M, Plate C, Summerfield M. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians.  Neurology . 1996;  46 1534-1539
    CrossrefPubMedGoogle Scholar
  • 7 Crawford P, Lee P. Gender differences in management of epilepsy: what women are hearing.  Seizure . 1999;  8 135-139
    CrossrefPubMedGoogle Scholar
  • 8 Seale C, Morrell M, Nelson L, Druzin M. Analysis of prenatal and gestational care given to women with epilepsy.  Neurology . 1998;  51 1039-1045
    PubMedGoogle Scholar
  • 9 Fairgrieve S D, Jackson M, Jonas P. Population based, prospective study of the care of women with epilepsy in pregnancy.  Br Med J . 2000;  321 674-675
    PubMedGoogle Scholar
  • 10 Devinsky O, Yerby M. Women with epilepsy.  Neurol Clin . 1994;  12 479-495
    PubMedGoogle Scholar
  • 11 Cantrell D. Epilepsy and pregnancy: a study of seizure frequency and patient demographics.  Epilepsia . 1997;  38 (suppl 8) 231
    PubMedGoogle Scholar
  • 12 Yerby M, Collins S. Pregnancy and the mother. In: Engel J, Pedley T, eds. Epilepsy, a Comprehensive Textbook Philadelphia: Lippincott-Raven 1997: 2027-2035
    Google Scholar
  • 13 Schmidt D, Canger R, Avanzini G. Change of seizure frequency in pregnant epileptic women.  J Neurol Neurosurg Psychiatry . 1983;  46 751-755
    CrossrefPubMedGoogle Scholar
  • 14 Stumpf D, Frost M. Seizures, anticonvulsants, and pregnancy.  Am J Dis Child . 1978;  132 746-748
    PubMedGoogle Scholar
  • 15 Zahn C A, Morrell M J, Collins S D, Labiner D M, Yerby M S. Management issues for women with epilepsy: a review of the literature.  Neurology . 1998;  51 949-956
    PubMedGoogle Scholar
  • 16 Teramo K, Hiilesmaa V. Pregnancy and fetal complications in epileptic pregnancies: review of the literature. In: Janz D, Bossi L, Dam M, eds. Epilepsy, Pregnancy and the Child New York: Raven Press 1982: 53-59
    Google Scholar
  • 17 Teramo K, Hiilesmaa V, Bardy A. Fetal heart rate during a maternal grand mal epileptic seizure.  J Perinat Med . 1979;  7 3-5
    PubMedGoogle Scholar
  • 18 Lindhout D, Meinardi H, Meijer J, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations.  Neurology . 1992;  42 (suppl 5) 94-110
    PubMedGoogle Scholar
  • 19 Samrén E, van Duijn C, Koch S. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.  Epilepsia . 1997;  38 981-990
    PubMedGoogle Scholar
  • 20 Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate.  Neurology . 1998;  51 904-906
    PubMedGoogle Scholar
  • 21 Yerby M, Devinsky O. Epilepsy and pregnancy. In: Devinsky O, Feldmann E, Hainline B, eds. Advances in Neurology: Neurological Complications of Pregnancy New York: Raven Press 1994: 45-63
    Google Scholar
  • 22 Pearlman M, Tintinalli J, Lorenz R. Blunt trauma during pregnancy.  N Engl J Med . 1990;  323 1609-1613
    CrossrefPubMedGoogle Scholar
  • 23 Pennell P, Gleba J, Clements S. Antiepileptic drug monitoring during pregnancy in women with epilepsy.  Epilepsia . 2000;  41 (suppl 7) 200
    PubMedGoogle Scholar
  • 24 Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate and during lactation.  Epilepsia . 2000;  41 709-713
    CrossrefPubMedGoogle Scholar
  • 25 Yerby M S. The use of anticonvulsants during pregnancy.  Semin Perinatol . 2001;  25 153-158
    PubMedGoogle Scholar
  • 26 Sathanandar S, Blesi K, Tran T, Leppik I. Lamotrigine clearance increases markedly during pregnancy.  Epilepsia . 2000;  26 (suppl 1) 246
    PubMedGoogle Scholar
  • 27 Levy R, Yerby M. Effects of pregnancy on antiepileptic drug utilization.  Epilepsia . 1985;  26 (suppl 1) S52-S57
    PubMedGoogle Scholar
  • 28 Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy.  Epilepsia . 1985;  26 631-635
    PubMedGoogle Scholar
  • 29 Hvas C, Henriksen T, Ostergaard J, Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight.  Br J Obstet Gynaecol . 2000;  107 896-902
    PubMedGoogle Scholar
  • 30 Yerby M, Collins S. Teratogenicity of antiepileptic drugs. In: Engel J, Pedley T, eds. Epilepsy, a Comprehensive Textbook Philadelphia: Lippincott-Raven 1997: 1195-1203
    Google Scholar
  • 31 Gilmore J, Pennell P B, Stern B J. Medication use during pregnancy for neurologic conditions. In: Evans R, ed. Neurologic Clinics: Iatrogenic Disorders Philadelphia: WB Saunders 1998: 189-206
    Google Scholar
  • 32 Arpino C, Brescianini S, Robert E. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE).  Epilepsia . 2000;  41 1436-1443
    PubMedGoogle Scholar
  • 33 Wide K, Winbladh B, Tomson T, Kallen B. Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years.  Epilepsia . 2000;  41 854-861
    PubMedGoogle Scholar
  • 34 Morrell M. Guidelines for the care of women with epilepsy.  Neurology . 1998;  51 (suppl 5) S21-S27
    PubMedGoogle Scholar
  • 35 Kaneko S, Battino D, Andermann E. Congenital malformations due to antiepileptic drugs.  Epilepsy Res . 1999;  33 145-158
    CrossrefPubMedGoogle Scholar
  • 36 Lindhout D, Omtzigt J, Cornel M. Spectrum of neural-tube defects in 34 infants perinatally exposed to antiepileptic drugs.  Neurology . 1992;  42 (suppl 5) 111-118
    PubMedGoogle Scholar
  • 37 Rosa F. Spina bifida in infants of women treated with carbamazepine during pregnancy.  N Engl J Med . 1991;  324 674-677
    PubMedGoogle Scholar
  • 38 Lindhout D, Schmidt D. In-utero exposure to valproate and neural tube defects.  Lancet . 1986;  2 1392-1393
    PubMedGoogle Scholar
  • 39 Samrén E, van Duijn C, Christiaens G, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring.  Ann Neurol . 1999;  46 739-746
    CrossrefPubMedGoogle Scholar
  • 40 Canger R, Battino D, Canevini M P. Malformations in offspring of women with epilepsy: a prospective study.  Epilepsia . 1999;  40 1231-1236
    PubMedGoogle Scholar
  • 41 Yerby M, Cawthon M. Fetal death, malformations and infant mortality in infants of mothers with epilepsy.  Epilepsia . 1996;  37 (suppl 5) 98
    PubMedGoogle Scholar
  • 42 Howe A, Oakes D, Woodman P, Webster W. Prothrombin and PIVKA-II levels in cord blood from newborn exposed to anticonvulsants during pregnancy.  Epilepsia . 1999;  40 980-984
    PubMedGoogle Scholar
  • 43 Srinivasan G, Seeler R A, Tiruvury A. Maternal anticonvulsant therapy and hemorrhagic disease of the newborn.  Obstet Gynecol . 1982;  59 250-252
    PubMedGoogle Scholar
  • 44 Nelson K B, Ellenber J H. Maternal seizure disorder, outcomes of pregnancy, and neurologic abnormalities in the children.  Neurology . 1982;  32 1247-1254
    PubMedGoogle Scholar
  • 45 Ganström M, Gaily E. Psychomotor development in children of mothers with epilepsy.  Neurology . 1992;  42 (suppl 5) 144
    PubMedGoogle Scholar
  • 46 Leonard G, Andermann E, Ptito A. Cognitive effects of antiepileptic drug therapy during pregnancy on school-age offspring.  Epilepsia . 1997;  38 (suppl 3) 170
    PubMedGoogle Scholar
  • 47 Meador K. Cognitive effects of epilepsy and of antiepileptic medications. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice 3rd ed. Philadelphia: Williams & Wilkins 2001: 1215-1226
    Google Scholar
  • 48 Leavitt A, Yerby M, Robinson N, Sells C, Erickson D. Epilepsy in pregnancy: developmental outcome of offspring at 12 months.  Neurology . 1992;  42(4 suppl 5) 141-143
    PubMedGoogle Scholar
  • 49 Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy.  J Neurol Neurosurg Psychiatry . 2001;  70 15-21
    CrossrefPubMedGoogle Scholar
  • 50 Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh J. Fetal valproate syndrome and autism: additional evidence of an association.  Dev Med Child Neurol . 2001;  43 202-206
    CrossrefPubMedGoogle Scholar
  • 51 Koch S, Titze K, Zimmerman R, Schroder M, Lehmkuhl U, Rauh H. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents.  Epilepsia . 1999;  40 1237-1243
    CrossrefPubMedGoogle Scholar
  • 52 Reinisch J, Sanders S, Mortensen E, Rubin D. In utero exposure to phenobarbital and intelligence deficits in adult men.  JAMA . 1995;  724 1518-1525
    PubMedGoogle Scholar
  • 53 Vanoverloop D, Schnell R, Harvey E, Holmes L. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age.  Neurotoxicol Teratol . 1992;  14 329-335
    CrossrefPubMedGoogle Scholar
  • 54 Battino D, Kaneko S, Andermann E. Intrauterine growth in the offspring of epileptic women: a prospective multicenter study.  Epilepsy Res . 1999;  36 53-60
    CrossrefPubMedGoogle Scholar
  • 55 Annegers J, Hauser W, Elveback L, Anderson V, Kurland L. Congenital malformations and seizure disorders in the offspring of parents with epilepsy.  Int J Epidemiol . 1978;  7 241-247
    PubMedGoogle Scholar
  • 56 Ottman R, Annegers J, Hauser W, Kurland L. Higher risk of seizures in offspring of mothers than fathers with epilepsy.  Am J Hum Genet . 1988;  43 357-364
    PubMedGoogle Scholar
  • 57 Holmes L B, Harvey E A, Coull B A. The teratogenicity of anticonvulsant drugs.  N Engl J Med . 2001;  344 1132-1138
    CrossrefPubMedGoogle Scholar
  • 58 Holmes L B, Rosenberger P B, Harvey E A, Khoshbin S, Ryan L. Intelligence and physical features of children of women with epilepsy.  Teratology . 2000;  61 196-202
    CrossrefPubMedGoogle Scholar
  • 59 Delgado-Escueta A, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy.  Neurology . 1992;  42 149-160
    PubMedGoogle Scholar
  • 60 Holmes L, Lieberman E. Report of first positive findings from hospital-based AED pregnancy registry.  Teratology . 2001;  63 250
    PubMedGoogle Scholar
  • 61 GlaxoSmithKline. Lamotrigine pregnancy registry, interim report, 9/1/92-3/30/01; 2001 . 
    Google Scholar
  • 62 Dansky L, Rosenblatt D, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy.  Neurology . 1992;  42 32-42
    PubMedGoogle Scholar
  • 63 Wegner C, Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanisms of teratogenesis.  Neurology . 1992;  42 (suppl 5) 17-24
    PubMedGoogle Scholar
  • 64 Botto L, Moore C, Khoury M, Erickson J. Medical progress: neural-tube defects.  N Engl J Med . 1999;  341 1509-1519
    CrossrefPubMedGoogle Scholar
  • 65 MRC Vitamin Study Research Group. Prevention of neural-tube defects: results of the Medical Research Council Vitamin Study.  Lancet . 1991;  338 131-137
    CrossrefPubMedGoogle Scholar
  • 66 Hall J, Solehdin F. Folic acid for the prevention of congenital anomalies.  Eur J Pediatr . 1998;  157 445-450
    CrossrefPubMedGoogle Scholar
  • 67 Crawford P. CPD-education and self-assessment: epilepsy and pregnancy.  Seizure . 2001;  10 212-219
    CrossrefPubMedGoogle Scholar
  • 68 American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy.  ACOG Education Bulletin. 1996;  No 231
    PubMedGoogle Scholar
  • 69 Buehler B A, Rao V, Finnell R H. Biochemical and molecular teratology of fetal hydantoin syndrome.  Pediatr Neurogenet . 1994;  12 741-748
    PubMedGoogle Scholar
  • 70 Pschirrer E, Monga M. Seizure disorders in pregnancy.  Obstet Gynecol Clin . 2001;  28 601-611
    PubMedGoogle Scholar
  • 71 Malone F, D'Alton M. Drugs in pregnancy: anticonvulsants.  Semin Perinatol . 1997;  21 114-123
    PubMedGoogle Scholar
  • 72 Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy.  Int J Gynecol Obstet . 1997;  56 279-286
    CrossrefPubMedGoogle Scholar
  • 73 Krauer B, Krauer F. Drug kinetics in pregnancy.  Clin Pharmacokinet . 1977;  2 167-181
    PubMedGoogle Scholar
  • 74 Fox C, Betts T. How much risk does a woman with active epilepsy pose to her newborn child in the puerperium?.  <~>A pilot study. Seizure . 1999;  86 367-369
    PubMedGoogle Scholar
  • 75 Hale T. Medications and Mothers' Milk.  8th ed. Amarillo, TX: Pharmasoft Medical Publishing; 1999
    Google Scholar
  • 76 Moore K. The Developing Human: Clinically Oriented Embryology.  4th ed. Philadelphia: WB Saunders; 1988
    Google Scholar
      >